122 related articles for article (PubMed ID: 38614528)
1. Prognostic value of brain perfusion by MRI in the initial study of high grade gliomas.
Fernández-Valverde F; Bautista-Bárcena MP; Roldán-Romero E; Solivera-Vela J; Bravo-Rodríguez F; Ramos-Gómez MJ
Radiologia (Engl Ed); 2024; 66(2):114-120. PubMed ID: 38614528
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
3. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
4. Probing the glioma microvasculature: a case series of the comparison between perfusion MRI and intraoperative high-frame-rate ultrafast Doppler ultrasound.
Alafandi A; Tbalvandany SS; Arzanforoosh F; van Der Voort SR; Incekara F; Verhoef L; Warnert EAH; Kruizinga P; Smits M
Eur Radiol Exp; 2024 Jan; 8(1):13. PubMed ID: 38273190
[TBL] [Abstract][Full Text] [Related]
5. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of perfusion MR imaging in patients with oligodendroglioma: A survival study.
Jiang Z; Le Bas JF; Grand S; Salon C; Pasteris C; Hoffmann D; Bing F; Berger F; Chabardes S; Liu C; Krainik A
J Neuroradiol; 2011 Mar; 38(1):53-61. PubMed ID: 20554324
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of high grade glioma and solitary brain metastases by measuring relative cerebral blood volume and fractional anisotropy: a systematic review and meta-analysis of MRI diagnostic test accuracy studies.
Fioni F; Chen SJ; Lister INE; Ghalwash AA; Long MZ
Br J Radiol; 2023 Jan; 96(1141):20220052. PubMed ID: 36278795
[TBL] [Abstract][Full Text] [Related]
9. Using Magnetic Resonance Perfusion to Stratify Overall Survival in Treated High-Grade Gliomas.
Fong C; Parpia S; Yemen B; Tsai S; Greenspoon J
Can J Neurol Sci; 2019 Sep; 46(5):533-539. PubMed ID: 31284880
[TBL] [Abstract][Full Text] [Related]
10. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours.
Fayed N; Modrego PJ
J Neurooncol; 2005 May; 72(3):261-5. PubMed ID: 15937650
[TBL] [Abstract][Full Text] [Related]
11. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
[TBL] [Abstract][Full Text] [Related]
12. Multimodel habitats constructed by perfusion and/or diffusion MRI predict isocitrate dehydrogenase mutation status and prognosis in high-grade gliomas.
Liu J; Cong C; Zhang J; Qiao J; Guo H; Wu H; Sang Z; Kang H; Fang J; Zhang W
Clin Radiol; 2024 Jan; 79(1):e127-e136. PubMed ID: 37923627
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy target volume definition in newly diagnosed high grade glioma using
Dissaux G; Dissaux B; Kabbaj OE; Gujral DM; Pradier O; Salaün PY; Seizeur R; Bourhis D; Ben Salem D; Querellou S; Schick U
Radiother Oncol; 2020 Sep; 150():164-171. PubMed ID: 32580001
[TBL] [Abstract][Full Text] [Related]
15. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
[TBL] [Abstract][Full Text] [Related]
16. Markers of angiogenesis (CD31, CD34, rCBV) and their prognostic value in low-grade gliomas.
Majchrzak K; Kaspera W; Szymaś J; Bobek-Billewicz B; Hebda A; Majchrzak H
Neurol Neurochir Pol; 2013; 47(4):325-31. PubMed ID: 23986422
[TBL] [Abstract][Full Text] [Related]
17. IVIM perfusion fraction is prognostic for survival in brain glioma.
Federau C; Cerny M; Roux M; Mosimann PJ; Maeder P; Meuli R; Wintermark M
Clin Neuroradiol; 2017 Dec; 27(4):485-492. PubMed ID: 27116215
[TBL] [Abstract][Full Text] [Related]
18. Semi-automated and automated glioma grading using dynamic susceptibility-weighted contrast-enhanced perfusion MRI relative cerebral blood volume measurements.
Friedman SN; Bambrough PJ; Kotsarini C; Khandanpour N; Hoggard N
Br J Radiol; 2012 Dec; 85(1020):e1204-11. PubMed ID: 23175486
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C
Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
[TBL] [Abstract][Full Text] [Related]
20. Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.
Usinskiene J; Ulyte A; Bjørnerud A; Venius J; Katsaros VK; Rynkeviciene R; Letautiene S; Norkus D; Suziedelis K; Rocka S; Usinskas A; Aleknavicius E
Neuroradiology; 2016 Apr; 58(4):339-50. PubMed ID: 26767528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
